Most Recent Articles about SNY
Sanofi Plans to Spin Off Drug Ingredient Business https://www.fool.com/investing/2020/02/24/sanofi-plans-to-spin-off-drug-ingredient-business.aspx?source=iedfolrf0000001 Feb 24, 2020 - The resulting spinoff would become the world's second largest drug ingredient producer.
Emergent (EBS) Earnings Miss in Q4, Revenues Beat Estimates http://www.zacks.com/stock/news/777571/emergent-ebs-earnings-miss-in-q4-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-777571 Feb 21, 2020 - Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.
Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval http://www.zacks.com/stock/news/777121/pharma-stock-roundup-azn-reports-q4-results-nvs-pfe-drugs-get-eu-approval?cid=CS-ZC-FT-analyst_blog|stock_roundup-777121 Feb 21, 2020 - AstraZeneca's (AZN) Q4 results were disappointing. European Commission approves Novartis (NVS) and Pfizer's (PFE) new drugs.

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
ABT Abbott Laboratories NYSE $67.67 $118.71B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals